IL-10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosis

European Journal of Immunology

Volumn 38, Issue 2, 2008, Pages 576-586

  Martinez Forero, Ivan ^a   Garcia Munoz, Ricardo ^b   Martinez Pasamar, Sara ^a   Inoges, Susana ^b   de Cerio, Ascensión Lopez Diaz ^b   Palacios, Ricardo ^a   Sepulcre, Jorge ^a   Moreno, Beatriz ^a   Gonzalez, Zaira ^a   Fernandez Diez, Begoña ^a   Melero, Ignacio ^b   Benandi, Maurizio ^b   Villoslada, Pablo ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

CD46; IL 10; MS; Stat 3; Tr1 cells

Indexed keywords

BETA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 10 RECEPTOR ALPHA; MEMBRANE COFACTOR PROTEIN; STAT1 PROTEIN; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL ACTIVITY; CELL ISOLATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FEMALE; FUNCTIONAL ASSESSMENT; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE FUNCTION; MALE; MULTIPLE SCLEROSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; WESTERN BLOTTING; CELL CULTURE; DOWN REGULATION; DRUG ANTAGONISM; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ADULT; CELLS, CULTURED; DOWN-REGULATION; FEMALE; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-10; MALE; MULTIPLE SCLEROSIS; RECEPTORS, INTERLEUKIN-10; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY;

EID: 42249086506     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200737271     Document Type: Article

References (40)

1. Diaz-Villoslada, P., Shih, A., Shao, L., Genain, C. P. and Hauser, S. L., Autoreactivity to myelin antigens: Myelin/oligodendrocyte glycoprotein is a prevalent autoantigen. J. Neuroimmunol. 1999. 99: 36-43.
2. Villoslada, P., Abel, K., Heald, N., Goertsches, R., Hauser, S. L. and Genain, C. P., Frequency, heterogeneity and encephalitogenicity of T cells specific for myelin oligodendrocyte glycoprotein in naive outbred primates. Eur. J. Immunol. 2001. 31: 2942-2950.
3. 't Hart, B. A., van Meurs, M., Brok, H. P., Massacesi, L., Bauer, J., Boon, L., Bontrop, R. E. and Laman, J. D., A new primate model for multiple sclerosis in the common marmoset. Immunol. Today 2000. 21: 290-297.
4. Zou, W., Regulatory T cells, tumour immunity and immunotherapy. Nat. Rev. Immunol. 2006. 6: 295-307.
5. Bluestone, J. A., Regulatory T-cell therapy: Is it ready for the clinic? Nat. Rev. Immunol. 2005. 5: 343-349.
6. Battaglia, M., Gregori, S., Bacchetta, R. and Roncarolo, M. G., Tr1 cells: From discovery to their clinical application. Semin. Immunol. 2006. 18: 120-127.
7. Meiffren, G., Flacher, M., Azocar, O., Rabourdin-Combe, C. and Faure, M., Cutting Edge: Abortive proliferation of CD46-induced Tr1-like cells due to a defective Akt/Survivin signaling pathway. J. Immunol. 2006. 177: 4957-4961.
8. + T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. J. Exp. Med. 2002. 196: 1335-1346.
9. Wildbaum, G., Netzer, N. and Karin, N., Tr1 cell-dependent active tolerance blunts the pathogenic effects of determinant spreading. J. Clin. Invest. 2002. 110: 701-710.
10. Gianfrani, C., Levings, M. K., Sartirana, C., Mazzarella, G., Barba, G., Zanzi, D., Camarca, A. et al., Gliadin-specific type 1 regulatory T cells from the intestinal mucosa of treated celiac patients inhibit pathogenic T cells. J. Immunol. 2006. 177: 4178-4186.
11. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997. 389: 737-742.
12. Levings, M. K., Sangregorio, R., Galbiati, F., Squadrone, S., de Waal, M. R. and Roncarolo, M. G., IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. J. Immunol. 2001. 166: 5530-5539.
13. Barrat, F. J., Cua, D. J., Boonstra, A., Richards, D. F., Crain, C., Savelkoul, H. F., Waal-Malefyt, R. et al., In vitro generation of interleukin 10- producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 2002. 195: 603-616.
14. + cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 2003. 421: 388-392.
15. Barchet, W., Price, J. D., Cella, M., Colonna, M., MacMillan, S. K., Cobb, J. P., Thompson, P. A. et al., Complement-induced regulatory T cells suppress T-cell responses but allow for dendritic-cell maturation. Blood 2006. 107: 1497-1504.
16. Ito, T.,Wang, Y. H., Duramad, O., Hanabuchi, S., Perng, O. A., Gilliet, M., Qin, F. X. and Liu, Y. J., OX40 ligand shuts down IL-10-producing regulatory T cells. Proc. Natl. Acad. Sci. USA 2006. 103: 13138-13143.
17. Steinman, L., Multiple sclerosis: A two-stage disease. Nat. Immunol. 2001. 2: 762-764.
18. Sospedra, M. and Martin, R., Immunology of multiple sclerosis. Annu. Rev. Immunol. 2005. 23: 683-747.
19. Antel, J. P., Richman, D. P., Medof, M. E. and Arnason, B. G., Lymphocyte function and the role of regulator cells in multiple sclerosis. Neurology 1978. 28: 106-110.
20. + regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 2004. 199: 971-979.
21. Astier, A. L., Meiffren, G., Freeman, S. and Hafler, D. A., Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis. J. Clin. Invest. 2006. 116: 3252-3257.
22. Soldan, S. S., Alvarez Retuerto, A. I., Sicotte, N. L. and Voskuhl, R. R., Dysregulation of IL-10 and IL-12p40 in secondary progressive multiple sclerosis. J. Neuroimmunol. 2004. 146: 209-215.
23. Huang, W. X., Huang, P., Link, H. and Hillert, J., Cytokine analysis in multiple sclerosis by competitive RT-PCR: A decreased expression of IL-10 and an increased expression of TNF-alpha in chronic progression. Mult. Scler. 1999. 5: 342-348.
24. Navikas, V., Link, J., Palasik, W., Soderstrom, M., Fredrikson, S., Olsson, T. and Link, H., Increased mRNA expression of IL-10 in mononuclear cells in multiple sclerosis and optic neuritis. Scand. J. Immunol. 1995. 41: 171-178.
25. Nakashima, I., Fujihara, K., Misu, T., Okita, N., Takase, S. and Itoyama, Y., Significant correlation between IL-10 levels and IgG indices in the cerebrospinal fluid of patients with multiple sclerosis. J. Neuroimmunol. 2000. 111: 64-67.
26. Yin, L., Yu, M., Edling, A. E., Kawczak, J. A., Mathisen, P. M., Nanavati, T., Johnson, J. M. and Tuohy, V. K., Pre-emptive targeting of the epitope spreading cascade with genetically modified regulatory T cells during autoimmune demyelinating disease. J. Immunol. 2001. 167: 6105-6112.
27. Riley-Vargas, R. C., Gill, D. B., Kemper, C., Liszewski, M. K. and Atkinson, J. P., CD46: Expanding beyond complement regulation. Trends Immunol. 2004. 25: 496-503.
28. Moore, K. W., de Waal, M. R., Coffman, R. L. and O'Garra, A., Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 2001. 19: 683-765.
29. Pestka, S., Krause, C. D., Sarkar, D., Walter, M. R., Shi, Y. and Fisher, P. B., Interleukin-10 and related cytokines and receptors. Annu. Rev. Immunol. 2004. 22: 929-979.
30. Kozovska, M. E., Hong, J., Zang, Y. C., Li, S., Rivera, V. M., Killian, J. M. and Zhang, J. Z., Interferon beta induces T-helper 2 immune deviation in MS. Neurology 1999. 53: 1692-1697.
31. Williams, L., Bradley, L., Smith, A. and Foxwell, B., Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. J. Immunol. 2004. 172: 567-576.
32. de Jonge, W. J., van der Zanden, E. P., The, F. O., Bijlsma, M. F., van Westerloo, D. J., Bennink, R. J., Berthoud, H. R. et al., Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat. Immunol. 2005. 6: 844-851.
33. Giorelli, M., Livrea, P. and Trojano, M., Post-receptorial mechanisms underlie functional disregulation of beta2-adrenergic receptors in lymphocytes from multiple sclerosis patients. J. Neuroimmunol. 2004. 155: 143-149.
34. Cosentino, M., Zaffaroni, M., Giorelli, M., Marino, F., Ferrari, M., Bombelli, R., Rasini, E. et al., Adrenergic mechanisms in multiple sclerosis: The neuro-immune connection? Trends Pharmacol. Sci. 2004. 25: 350-351; author reply 351-352.
35. Xystrakis, E., Kusumakar, S., Boswell, S., Peek, E., Urry, Z., Richards, D. F., Adikibi, T. et al., Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J. Clin. Invest. 2006. 116: 146-155.
36. Baecher-Allan, C. and Hafler, D. A., Suppressor T cells in human diseases. J. Exp. Med. 2004. 200: 273-276.
37. McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H. P., Lublin, F. D., McFarland, H. F. et al., Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 2001. 50: 121-127.
38. He, X. S., Ji, X., Hale, M. B., Cheung, R., Ahmed, A., Guo, Y., Nolan, G. P. et al., Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race. Hepatology 2006. 44: 352-359.
39. Muller, P. Y., Janovjak, H., Miserez, A. R. and Dobbie, Z., Processing of gene expression data generated by quantitative real-time RT-PCR. Biotechniques 2002. 32: 1372-1374.
40. Moreno, B., Hevia, H., Santamaria, M., Sepulcre, J., Munoz, J., Garcia-Trevijano, E. R., Berasain, C. et al., Methylthioadenosine reverses brain autoimmune disease. Ann. Neurol. 2006. 60: 323-334.